PC346C 9 [DCC J] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC J)
PC346C 8 [DCC H] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC H)
PC346C 7 [DCC G] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC G)
PC346C 6 [DCC F] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC F)
PC346C 5 [DCC D] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC D)
PC346C 4 [DCC C] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC C)
PC346C 3 [DCC B] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC B)
PC346C 2 [DCC A] CRPC Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Dextran-coated charcoal-stripped FCS (DCC A)
PC346C 1 [Source] Cell line Product
CRPC PC346C cell lines (27 sublines made resistant to common antiandrogens) – Source line
PC346C-FLU2 AR (T877A) mutated CRPC Cell line Product
PC346C-FLU2 AR (T877A) mutated CRPC Cell line: Human prostate 2D cancer cell line, AR (T877A) mutation
